Alcohol Use Disorder
American Association of Psychiatric Pharmacists (AAPP)
American Psychiatric Association (APA)
American Society of Addiction Medicine (ASAM)
Society for Academic Emergency Medicine (SAEM)
Substance Abuse and Mental Health Services Administration (SAMHSA)
World Federation of Societies of Biological Psychiatry (WFSBP)
- Treatment of alcohol use disorders in pregnant women (2019)
- Guidelines for biological treatment of substance and related disorders, part 1: Alcoholism, first revision (2017)
Stimulant Use Disorder
American Association of Psychiatric Pharmacists (AAPP)
American Society of Addiction Medicine (ASAM) and American Academy of Addiction Psychiatry (AAAP)
Substance Abuse and Mental Health Services Administration (SAMHSA)
Opioid Use Disorder
American Association of Psychiatric Pharmacists (AAPP)
- Pharmacist toolkit: Buprenorphine initiation and dosing strategies (2024)
- Pharmacist toolkit: Medication management of opioid use disorder (2023)
American Society of Addiction Medicine (ASAM)
Canadian Institutes of Health Research (CIHR)
- Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline (2019)
- Management of opioid use disorders: A national clinical practice guideline (2018)
College of Family Physicians of Canada
National Community Pharmacists Association (NCPA) / National Association of Boards of Pharmacy (NABP)
- The Pharmacy Access to Resources and Medication for Opioid Use Disorder (PhARM-OUD) Guideline (2024)
Substance Abuse and Mental Health Services Administration (SAMHSA)
- Overdose prevention and response toolkit (2024)
- Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) practice guide (2023)
- Medications for opioid use disorder (2021)
- Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants (2018)
- Federal guidelines for opioid treatment programs (2015)
World Federation of Societies of Biological Psychiatry (WFSBP)
World Health Organization (WHO)
Sedative, Hypnotic, or Anxiolytic (Benzodiazepine) Use Disorder
American Association of Psychiatric Pharmacists (AAPP)
Tobacco Use Disorder
US Department of Health and Human Services
US Preventive Services Task Force (USPSTF)
Other
American Association of Psychiatric Pharmacists (AAPP)
- Pharmacist toolkit: Harm reduction strategies for people who inject drugs (2022)
- Pharmacist toolkit: Xylazine (2023)
American Psychiatric Association (APA)
British Association of Psychopharmacology (BAP)
Substance Abuse and Mental Health Services Administration (SAMHSA)
- Treating substance use disorder in older adults (2020)
- Detoxification and substance abuse treatment (2015)
Veterans Affairs/Department of Defense
World Health Organization (WHO)
Reviewer 1: Roisin Sabol, PharmD
Reviewer 2: Austin Smith, PharmD, BCPP
2024-2025 AAPP Resident and New Practitioner Committee